OTC - ACTIVE INGREDIENT SECTION
red ginseng powder
red ginseng powder
coriolus versicolorr, licorice, aralia continentalis, houttuynia cortata, cnidium officinale, cinnamon bark, houttuynia, mulberry leaf, astragalus membranaceus, gigantic angelica, sweet rush, pepper, bongchul, plueropterus multiflorus, dired clove, caramel
To improve blood circulation and immunity, vitalize body parts and produce nerve cells
keep out of reach of the children
■ Take 2 times a day
■ do not use if having a cardiac disorder
■ Ask a doctor before taking more than 8 tablets.
for oral use only
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 58370-3001-1 | 2019-11-27 | C162847 | 48780-1 | 9855d018-dcaf-cd31-e053-dbdaa90ab51a | Drug Facts |
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 58370-3001-1 | SOMA Pet-circle | 75 g in 1 BOTTLE | POWDER | 75 | 1 |
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 58370-3001 | SOMA PET-CIRCLE (ASIAN GINSENG) POWDER [SOMA BIOTECHNOLOGY CO., LTD] | 1 | Legacy NDC, 1 package rows | 20130502_fdd592af-7aab-4fa0-ac36-7ac8f2dc3c24.zip |
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| ASIAN GINSENG | ACTIVE INGREDIENT | CUQ3A77YXI | 1 | |
| ASIAN GINSENG | ACTIVE MOIETY | CUQ3A77YXI | 1 | |
| ACORUS GRAMINEUS ROOT | INACTIVE INGREDIENT | Z60N6Q6E19 | 1 | |
| ANGELICA SINENSIS ROOT | INACTIVE INGREDIENT | B66F4574UG | 1 | |
| ARALIA CORDATA ROOT | INACTIVE INGREDIENT | 6KW7950A8P | 1 | |
| ASTRAGALUS PROPINQUUS ROOT | INACTIVE INGREDIENT | 922OP8YUPF | 1 | |
| CARAMEL | INACTIVE INGREDIENT | T9D99G2B1R | 1 | |
| CINNAMON | INACTIVE INGREDIENT | 5S29HWU6QB | 1 | |
| CLOVE | INACTIVE INGREDIENT | K48IKT5321 | 1 | |
| CNIDIUM OFFICINALE WHOLE | INACTIVE INGREDIENT | E9V83DB6BY | 1 | |
| GLYCYRRHIZA GLABRA | INACTIVE INGREDIENT | 2788Z9758H | 1 | |
| HOUTTUYNIA CORDATA FLOWERING TOP | INACTIVE INGREDIENT | RH041UUZ22 | 1 | |
| MORUS AUSTRALIS LEAF | INACTIVE INGREDIENT | IR0M74L573 | 1 | |
| PEPPERS | INACTIVE INGREDIENT | T5KDM4J239 | 1 | |
| POLYGONUM CUSPIDATUM WHOLE | INACTIVE INGREDIENT | 1VDG5Y5HS6 | 1 | |
| TRAMETES VERSICOLOR FRUITING BODY | INACTIVE INGREDIENT | 4C900477MT | 1 | |
| ZEDOARY | INACTIVE INGREDIENT | 123C43G128 | 1 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 58370-3001 | 58370-3001-1 |
Every source-derived ingredient row is available through these pages.
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| CARAMEL | CARAMEL | T9D99G2B1R | CREAM / TOPICAL | 0.26 %w/w | ||
| CARAMEL | CARAMEL | T9D99G2B1R | SUSPENSION / ORAL | 111.12 mg/5ml | ||
| CARAMEL | CARAMEL | T9D99G2B1R | CAPSULE / ORAL | NA | ||
| CINNAMON | CINNAMON | 5S29HWU6QB | CAPSULE / ORAL | NA | ||
| CINNAMON | CINNAMON | 5S29HWU6QB | ELIXIR / ORAL | 10.5 mg/5ml | ||
| CARAMEL | CARAMEL | T9D99G2B1R | LOTION / TOPICAL | NA | ||
| CARAMEL | CARAMEL | T9D99G2B1R | SOLUTION / RECTAL | NA | ||
| CARAMEL | CARAMEL | T9D99G2B1R | LIQUID / ORAL | 5.3 mg | ||
| CARAMEL | CARAMEL | T9D99G2B1R | SYRUP / ORAL | 207 mg/5ml | ||
| CARAMEL | CARAMEL | T9D99G2B1R | GRANULE, FOR SUSPENSION / ORAL | 2.5 mg/5ml | ||
| CARAMEL | CARAMEL | T9D99G2B1R | SOLUTION / ORAL | 11 mg |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| ed857f19-7804-4cd3-9cd1-ce2ad2b70f7f | fdd592af-7aab-4fa0-ac36-7ac8f2dc3c24 | 2013-05-02 | Warnings | ed857f19-7804-4cd3-9cd1-ce2ad2b70f7f fdd592af-7aab-4fa0-ac36-7ac8f2dc3c24 |
Adverse event summaries are temporarily unavailable. Other product information remains available.